Our genomic investigation revealed 2 new candidate X-linked drivers of T-ALL: USP9X and MED12. For USP9X, we identified a novel truncating mutation (p.Q117*) in exon 5 carried by the unclassified male patient 194 suggesting a tumor suppressor role (Figure 3C). Here, USP9X is linked to neoplasm.